Introduction
The two external glycoproteins of human respiratory syncytial (RS) virus, designated G and F, are responsible for cell attachment (Levine et al., 1987) and cell fusion, respectively (Walsh & Hruska, 1983) . The G protein is synthesized as a 36K precursor (Wertz et al., 1985; Satake et al., 1985) which is modified extensively by the addition of N-and O-linked oligosaccharide chains to yield a mature molecule of 80K to 90K Lambert, 1988) . The F protein precursor (Fo), synthesized as a 56K polypeptide, is modified by both N-linked glycosylation and proteolytic cleavage to generate the disulphide-bonded F1 (49K) and F2 (20K) subunits (Gruber & Levine, 1983; Lambert & Pons, 1983) .
Carbohydrates may influence dramatically the antigenicity of viral glycoproteins. For instance, heteroantisera raised against fully glycosylated retrovirus or influenza virus were virtually unreactive with the viral glycoproteins after carbohydrate removal (Alexander & Elder, 1984) . In other cases, oligosaccharide side-chains on the haemagglutinin of influenza virus inhibited its recognition by monoclonal antibodies (MAbs; Skehel et al., 1984) .
Since oligosaccharide chains represent two-thirds of the molar mass of the mature G protein of RS virus, it was important to evaluate their contribution to the antigenic structure of this molecule. As a first step, we I" Present address: CLONTEC, S.A., Facultad de Medicina, 31080 Pamplona, Spain. have determined the influence of carbohydrates in the reactivity of the G glycoprotein with a panel of 18 MAbs (Garcia-Barreno et al., 1989) . In addition, we have analysed the specificities of human anti-G antibodies present in post-infection sera in two ways: firstly, by estimating their capacity to inhibit the binding to virus of labelled anti-G MAbs and secondly, by evaluating the reactivity of human sera with viruses resistant to one anti-G antibody.
Methods
Viruses. The Long strain of human RS virus was used as the prototype throughout. It was grown in Hep-2 cells and purified from culture supernatants as previously described (Garcia-Barreno et aL, 1988) . The selection of the mutant viruses (R63/2/4/1, R63/4/10]5 and R63/8/7/2) resistant to MAb 63G has been described (Garcia-Barreno et al, 1990) .
Antibodies. The MAbs used in this study were raised in BALB/c mice immunized with the Long strain of RS virus. Their preparation and characterization have been described (Garcla-Barreno et al., 1989) .
The human sera were taken between 1985 and 1987 from children recovering from RS virus infection. The sera had titres between 256 and 4096 in a complement fixation assay (virion).
The hyperimmune anti-RS virus serum was prepared in New Zealand white rabbits inoculated subcutaneously with three doses (100 p.g) of the Long strain at 15 day intervals. The first dose was mixed with an equal volume (0.5 ml) of complete Freund's adjuvant and the other two with incomplete adjuvant. Blood was collected 1 week after the last injection. cells were scraped off with a rubber policeman and washed with phosphate-buffered saline by low speed centrifugation. Finally, the cells were resuspended in lysis buffer (10 mM-Tris-HCl pH 7.5, 140 mMNaC1, 5 mM-EDTA and 1~ N-octyl-fl-D-glucopyranoside) and the extracts centrifuged at 12000 g for 5 rain. The supernatants were kept at -20 °C until used.
For tunicamycin treatment, cells were infected and the drug was added to the culture medium 2 h p.i. at 2 ~g/ml. Cells were harvested and extracts were made as indicated above. Protein content was estimated by the Lowry method (Lowry et al., 1951) .
Western blot. Proteins from either cell extracts or purified virus were separated by SDS-PAGE (Studier, 1972) and electrotransferred to nitrocellulose paper (Immobilon, Millipore) by the method of Towbin et al. (1979) . The paper was cut into longitudinal strips and incubated with antibodies. The antigen-antibody complexes were then developed using biotinylated anti-mouse, -human or -rabbit antisera, streptavidin-peroxidase and 4-chloro-l-naphthol as recommended by the manufacturer (Amersham).
Competitive binding of MAbs and antibodies from human sera to purified RS virus. MAbs were purified from ascitic fluids by Protein ASepharose chromatography (Garcia-Barreno et al., 1989) and peroxidase-labelled by the glutaraldehyde procedure (Avrameas & Ternynck, 1971) . Each antibody was titrated in a direct ELISA using purified virus to coat the wells of PVC microtitre plates. The antibody dilution that gave 80~ of the maximum value was incubated with different dilutions of human or rabbit sera and re-tested. The titres of the competing antisera were calculated from the reciprocal of the serum dilution at which the absorbance was 50 ~ of the value obtained in their absence. Control human or rabbit antisera did not reduce the ELISA values significantly.
Results

Reactivity of MAbs with different glyeosylated forms of the G protein
Hep-2 cells, infected with the RS virus Long strain, were treated with tunicamycin to inhibit the lipid-dolicholmediated N-linked glycosylation of asparagine residues (Takatsuki et al., 1975) . Cell extracts were made and tested by Western blotting using a pool of 18 MAbs directed against the RS virus G glycoprotein (GarciaBarreno et al., 1989) . Extracts of infected cells without the drug and purified virus were included as controls.
The results obtained (Fig. 1 a) indicate that the main component recognized by the antibodies in extracts without tunicamycin and virions was a diffuse band of 80K to 90K corresponding to the mature G molecule; however, other minor bands of 40K to 60K, corresponding to maturation intermediates (Fernie et al., 1985; Lambert, 1988) , were also observed under the same conditions. In tunicamycin-treated cell extracts, the pool of anti-G antibodies reacted with an 80K band, previously identified as an O-linked glycosylated form of the G protein (Lambert, 1988 ) and a 36K band corresponding to the unglycosylated precursor (Wertz et al., 1989) . This band comigrates with a cell-free Individual antibodies were similarly tested against infected cell extracts with or without tunicamycin and purified virus. The reactivity of the antibodies was evaluated against the following forms of G: the fully glycosylated G protein (80K to 90K band), the 40K to 60K intermediates, the O-glycosylated form (80K band) and the 36K unglycosylated precursor. Fig. l(b) shows some representative results. Although quantitative differences were detected in the intensity of bands recognized by individual antibodies compared to the antibody pool, the following reactivities were observed. Antibodies 8G and 72G reacted with the fully glycosylated (80K to 90K) and the O-glycosylated (80K) forms but recognized neither the 40K to 60K intermediates nor the unglycosylated 36K band; antibody 74G recognized the fully glycosylated form and to a lesser extent the Oglycosylated and unglycosylated precursors; antibody 25G reacted with the mature form, the 40K to 60K intermediates and the unglycosylated precursor but failed to react with the O-glycosylated form.
The Western blot results obtained with 18 anti-G MAbs are summarized in • 84K
• 47K
• 33K 
Specificities of antibodies present in human sera
To obtain information on the specificities of antibodies in human post-infection sera, we used a competitive assay which involved estimating the binding to virus of labelled anti-RS virus MAbs in the presence of the sera under analysis. Representative results obtained with two antibodies are shown in Fig. 2 . All antisera inhibited more than 75~o of binding of antibody 2F (Fig. 2a) , which recognizes the F glycoprotein of RS virus. In contrast, only some antisera at low dilutions inhibited the binding of the anti-G antibody 63G (Fig. 2b) . The results of similar competitive ELISAs done with representative antibodies directed against the F and G glycoproteins are summarized in Table 2 . Most human sera had high titres of antibodies which inhibited the binding to virus of the anti-F antibodies tested. In contrast, only some sera contained antibodies which at low dilutions inhibited the binding of antibody 63G. No significant reduction of binding to virus was observed with the other anti-G MAbs tested.
Since the lack of competition could be explained by the absence of anti-G antibodies in human sera, these were tested by Western blotting against purified Long virus. The results obtained (Fig. 3) indicated that most antisera reacted with the major virion components, including the G protein. However, quantitative differences were observed when the protein patterns generated by different antisera were compared. For instance, serum 5 reacted poorly with the G protein although it recognized other viral components efficiently. The recognition of the F or G proteins in W e s t e r n blots did not correlate with the inhibition of binding results (Table 2) . F o r instance, serum 7 which reacted weakly with the F protein in W e s t e r n blots had significant titres of binding inhibition with the anti-F antibodies. In other cases, h u m a n antisera which recognized the G protein in Western blots did not inhibit the virus-binding of a n t i -G antibodies, including 63G. These results indicate that the specificities of the h u m a n antibodies reacting in W e s t e r n blots and competitive E L I S A s were different.
A h y p e r i m m u n e rabbit antiserum raised against the Long strain of RS virus also contained antibodies which, RS 1 2 3 4 5 6 7 8 9 10 11 12 13 Fig. 3 . Immunoblots of the proteins from the Long strain with human antisera. Proteins (20 p.g) extracted from purified Long virus were tested by Western blotting with the human antisera of Table 2 (1 : 100 dilution), indicated at the top of each lane. RS denotes a lane developed with a hyperimmune rabbit antiserum. The positions of the major viral proteins are denoted in the left-hand margin. Slight differences in the mobilities of the viral proteins are due to several gels being used in the assay.
at high dilutions, inhibited the binding of anti-F antibodies. In contrast, the binding of a n t i -G antibodies was reduced only by low dilutions of the rabbit serum (Table 2) . However, murine antibodies present in an antiserum aliquot from the mouse used in the preparation of the anti-RS virus M A b s showed high inhibitory titres with three a n t i -F and two anti-G antibodies tested. This result suggests variations in the range of the a n t i -G antibody specificities elicited in different species.
Reactivity of human serum with antibody escape mutants
A n alternative procedure to evaluate the relationship between the specificities of h u m a n and mouse anti-G antibodies was to test whether or not h u m a n antibodies would react with the G protein of M A b -r e s i s t a n t viruses. 
1990
). Three mutant viruses (R63/2/4/1, R63/4/10/5 and R63/8/7/2) were used in the present study and their characteristics are summarized as follows.
The mutant R63/2/4/1 G protein contains a single adenosine deleted after nucleotide 623 and an A inserted seven triplets later when compared to the Long strain. These changes, leading to frameshift mutations, would predict a protein of the same length as Long with seven amino acids (residues 205 to 211) changed. The R63/2/4/1 G protein has lost the capacity to bind MAb 63G but reacts with all other anti-G MAbs. The G sequence of the other two mutants contains a single A deleted after nucleotide 623, generating polypeptides shorter by 25 amino acids than the Long strain and with the last 69 amino acids (residues 205 to 273) changed. The G proteins of mutants R63/4/10/5 and R63/8/7/2 have lost the capacity to bind most anti-G MAbs, indicating that the carboxy-terminal third of the G polypeptide is essential to maintain the integrity of these epitopes.
Purified virions of the Long strain and the three mutants resistant to antibody 63G were tested in Western blots with human post-infection (Fig. 4d) and rabbit hyperimmune anti-RS virus (Fig. 4c) sera. As controls, the viruses were tested separately with MAbs 63G (Fig. 4a) and 25G (Fig. 4b ) mixed with anti-NP Ib  II  IV  I  II  III  VII  VIII  area   Serum  MAb  2F  44F  53F  75F  47F  52F  57F  25G  63G  68G  62G  26G  74G  77G Fig. 2 for 2F and 63G. The antiserum titres in the virus-binding inhibition assay with each MAb were estimated by interpolation from curves such as those of Fig. 2 . The titre indicates the reciprocal of the serum dilution that reduced the ELISA reading by 50% The human sera are numbered sequentially, with the year in which they were taken. Controls of hyperimmune rabbit serum and serum from a mouse used to obtain the MAbs were included in the assay.
1" (-), No competition. NO, Not determined.
MAb 79N, included to standardize the amount of viral antigen in each lane. The G proteins of mutants R63/4/10/5 and R63/8/7/2 were recognized by neither the antisera nor the MAbs. Since both viruses contain drastic sequence changes in the carboxy-terminal third of the G molecule, the results of Fig. 4 indicate that this segment of the G polypeptide is essential for the integrity of epitopes recognized by antibodies present in human and rabbit antisera as well as murine MAbs. In agreement with this hypothesis, the G protein of mutant R63/2/4/1, which is altered only at amino acids 205 to 211, is recognized by MAb 25G and by human and rabbit antisera.
Discussion
We have studied the reactivity of MAbs with different glycosylated forms of the G protein of human RS virus. The results obtained indicate that the O-linked carbohydrates are necessary for the binding of most anti-G antibodies. The external domain of the G protein contains only four potential sites for N-glycosylation but it has more than 70 serine and threonine residues susceptible to O-glycosylation (Satake et al., 1985; Wertz et al., 1985; Johnson et al., 1987) . Studies using either glycosylation inhibitors (Lambert, 1988) or O-glycosylation-deficient cells (Wertz et al., 1989) indicate that the O-linked sugars contribute predominantly to the molecular mass of the mature G protein. In addition, virus infectivity has been shown to be sensitive to the limited removal of O-linked oligosaccharides (Lambert, 1988) . Thus, the post-translational addition of O-linked sugars seems to be a very important modification for the functional and antigenic properties of the G molecule. The different behaviour of human antibodies in the virus-binding inhibition of either anti-G or anti-F MAbs is striking. The failure of human antibodies to inhibit the virus-binding of most murine anti-G antibodies can be interpreted in, at least, two different ways.
Firstly, immunodominant epitopes of the RS virus G protein in the murine system might be irrelevant during the course of natural infections. This difference in immunodominance could reflect variations of the immune response between animal species or inoculation routes. In this sense, Wagner et al. (1986) have shown that the human immune response elicited by the G molecule is primarily IgG 1 and IgG3, indicating that the protein moiety might be immunodominant in humans. We have also observed that human sera reacted in Western blots with the unglycosylated precursor of the G protein (data not shown). Nevertheless, the human sera failed also to inhibit the virus-binding of anti-G antibodies which recognized the unglycosylated precursor (Table 2) . Secondly, since the mouse anti-G MAbs are mainly strain-specific (Garcia-Barreno et al., 1989) , it is possible that human sera contain antibodies directed against the equivalent epitopes of viruses in circulation during the corresponding outbreaks. This influence of antigenic variation in the lack of competition between human antibodies present in post-infection sera and mouse MAbs has been documented for the influenza virus haemagglutinin (Wang et al., 1986) . In agreement with this possibility, Hendry el al. (1988) have reported the presence in human post-infection anti-RS virus sera of subgroup-specific anti-G antibodies. Although the human sera used in our study reacted in Western blots with the G protein of several strains, including subgroup B viruses (data not shown), the specificities of antibodies reacting in Western blots and ELISAs might be different. Thus, the presence of strain-specific anti-G antibodies in human sera, equivalent to the murine anti-G MAbs, remains a possibility which deserves further investigation. In fact, the specificities of the human anti-G antibodies seem to be structurally related to the epitopes recognized by murine MAbs. This is supported by the results shown in Fig. 4 . The G protein of mutant viruses R63/4/10/5 and R63/8/7/2 was neither recognized by human post-infection serum nor most anti-G MAbs (Garcia-Barreno et al., 1989) . Since both mutants contain extensive amino acid sequence changes in the carboxyterminal third of the G polypeptide (Garcia-Barreno et al., 1990) , it seems that this part of the molecule plays an essential role in determining the structure of the G epitopes recognized by both human and murine antibodies.
